LIMAA Technologies and Labor Becker announce strategic partnership
Better generate, manage and analyze histopathology data on a large scale
LIMAA Technologies, an innovative deep-tech startup in the field of medical technology solutions, is proud to announce a strategic partnership with Labor Becker, one of Germany’s largest and owner-managed diagnostic laboratories. The collaboration is set to accelerate the development of LIMAA's end-to-end histopathology platform, enhancing scalability and precision in tissue diagnostics, including integrated genomics.
By combining LIMAA's cutting-edge histopathology technology with Labor Becker's extensive laboratory activities, the partnership will streamline diagnostic workflows, reduce turnaround times, and significantly improve patient outcomes by delivering more accurate and comprehensive results. The development will allow healthcare providers to better generate, manage and analyze histopathology data on a large scale.
CEO of LIMAA Technologies, Dr. Fabian Mohr, emphasized the importance of this collaboration: "Partnering with Labor Becker marks a significant milestone in our mission to democratize access to advanced tissue diagnostics. Our scalable histopathology platform is designed to empower pathologists with faster, more precise tools while driving greater efficiency across labs of all sizes. Together with Labor Becker, we are taking a pivotal step towards transforming the future of diagnostics and patient care.”
LIMAA's histopathology platform offers a fully integrated digital workflow encompassing sample preparation, AI-powered image analysis, and cloud-based reporting. With scalability at its core, the platform is designed to accommodate the needs of both smaller clinics and large laboratory networks.
CEO of Labor Becker, Dr. Marc Becker, also shared excitement for the collaboration: "At Labor Becker, we continually strive to enhance the efficiency and accuracy of our diagnostics, and this partnership with LIMAA is an ideal match. Their histopathology platform enables us to offer cutting-edge diagnostics, streamline operations, and reduce turnaround times, all while maintaining top-quality pathology services. We're excited to push the boundaries of what's possible in histopathology together."
Other news from the department business & finance
Most read news
More news from our other portals
Something is happening in the life science industry ...
This is what true pioneering spirit looks like: Plenty of innovative start-ups are bringing fresh ideas, lifeblood and entrepreneurial spirit to change tomorrow's world for the better. Immerse yourself in the world of these young companies and take the opportunity to get in touch with the founders.
See the theme worlds for related content
Topic world Diagnostics
Diagnostics is at the heart of modern medicine and forms a crucial interface between research and patient care in the biotech and pharmaceutical industries. It not only enables early detection and monitoring of disease, but also plays a central role in individualized medicine by enabling targeted therapies based on an individual's genetic and molecular signature.
Topic world Diagnostics
Diagnostics is at the heart of modern medicine and forms a crucial interface between research and patient care in the biotech and pharmaceutical industries. It not only enables early detection and monitoring of disease, but also plays a central role in individualized medicine by enabling targeted therapies based on an individual's genetic and molecular signature.
Last viewed contents
A new way to stimulate cellular recycling process
Thermo Fisher Scientific and QIAGEN N.V. Agree on Amended Terms to Acquisition Agreement - Offer price increased
New insights into the function of a risk factor for Alzheimer’s disease - Researchers decipher the structure-function relationship of the multifunctional protein clusterin for the first time
Rigaku opens Rigaku Technology Center Taiwan - Advancing regional growth through engineering and collaboration in Taiwan and beyond
Multiplexed Morse signals from cells
Lab901 and Biofortuna to collaborate on automated PCR Dx for HLA and Coeliac disease
Closing in on the elusive rotational-vibrational CH5+ spectra
New model predicts a chemical reaction’s point of no return - Chemists could use this quick computational method to design more efficient reactions that yield useful compounds, from fuels to pharmaceuticals
Fondant under the magnifying glass - New insights into the properties of sweet coating: The results could be used to optimize the industrial production process in the future
